DexCom

Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

Founded in 2017, Phenomix Sciences is a biotechnology company specializing in metabolomics and genomics. It develops precision medicine tools for chronic disease management, focusing on obesity. The company's AI-driven platform offers a novel blood test to classify patients' unique pathophysiological phenotypes, enabling personalized treatment with improved efficacy and fewer side effects.

Current Health Limited is a healthcare technology company based in Edinburgh, United Kingdom, that specializes in wearable devices for monitoring patient vitals. Founded in 2014 and originally known as Snap40 Limited, the company rebranded in December 2018. Current Health's devices are designed to measure critical health indicators such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, enabling early identification of potential health issues. Their patient monitoring platform facilitates the management of patients at home by collecting and analyzing data to detect and predict health deterioration. This allows patients to share daily activities, report symptoms, and complete structured questionnaires, ultimately helping healthcare providers reduce risks and costs associated with patient care.

Beta Bionics is a medical device company focused on diabetes care, developing and commercializing the iLet Bionic Pancreas System. The iLet uses adaptive closed-loop algorithms to automate insulin delivery and glucose management for people with insulin-requiring diabetes, with configurations that support bihormonal approaches. The company designs, manufactures, and markets the system to the diabetes community, aiming to simplify treatment and improve health outcomes by reducing the burden of daily insulin dosing and monitoring. Through its single-segment business model, Beta Bionics centers on bringing the iLet from development to commercialization.

TypeZero Technologies LLC is a healthcare technology company based in Charlottesville, Virginia, focused on diabetes management solutions. Incorporated in 2013, it has developed the inControl Diabetes Management Platform, which includes an innovative smartphone-based artificial pancreas that automates insulin delivery, significantly reduces the risk of hypoglycemia, and improves blood glucose levels. Additionally, the platform features inControl Advice, a mobile advisory system that provides real-time recommendations for meal planning, basal rates, bolus calculations, and exercise decisions. TypeZero also offers inControl Cloud, a suite of cloud-based tools that enable real-time monitoring and notifications for caregivers and family members, as well as retrospective data analysis to identify treatment inefficiencies. As of August 2018, TypeZero operates as a subsidiary of DexCom, Inc.

Nintamed is a distribution company operating in Germany, Switzerland, and Austria, specializing in products for diabetes management. The company develops a continuous glucose monitoring system that enables patients to track their blood sugar levels effectively. Additionally, Nintamed produces pen needles designed for the administration of insulin, enhancing the convenience and comfort of diabetes care. Through its innovative products, Nintamed aims to improve the quality of life for individuals living with diabetes.

SweetSpot Diabetes Care is a health data company dedicated to enhancing diabetes management through effective data utilization. It specializes in transforming raw data from patient devices into comprehensive reports that serve researchers, healthcare providers, and patients alike. By facilitating the download and analysis of device data, SweetSpot simplifies the process for endocrinology clinics, enabling them to generate essential reports for doctors, nurses, and diabetes educators. This service alleviates the complexities associated with multiple data interfaces and formats, allowing healthcare providers to gain insights into patients' blood glucose levels, patterns, and fluctuations. Ultimately, SweetSpot aims to empower patients with self-service tools for data retrieval and management, improving overall diabetes care and enabling clinics to optimize their time and resources.